Pharmacological research on 4,5-diphenyl-2-bis(2-hydroxyethyl)-aminoxazol (Ditazol), a new synthetic oxazole derivative as an anti-inflammatory agent.
D000284:Administration, Oral; D000287:Administration, Topical; D000315:Adrenalectomy; D000700:Analgesics / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001831:Body Temperature / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D004487:Edema / Q000188:drug therapy; D004983:Ethanolamines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006099:Granuloma / Q000188:drug therapy; D006145:Guanethidine / Q000494:pharmacology; D006358:Hot Temperature; D008297:Male; D051379:Mice; D010080:Oxazoles / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012640:Seizures / Q000188:drug therapy
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D004983:Ethanolamines; D010080:Oxazoles; D012110:Reserpine; D010653:Phenylbutazone; D006145:Guanethidine